I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
Retinal Vascular Occlusions: Understanding and Protecting Your Vision
Understanding Retinal Vascular Occlusions
The retina depends on a continuous, healthy flow of blood to function properly. When a blood vessel supplying the retina becomes blocked, the result can be rapid and serious damage to vision. Understanding the different types of occlusions helps clarify why prompt care is so important.
A retinal vascular occlusion is a blockage in one of the blood vessels that serves the retina. The retina relies on arteries to deliver oxygen-rich blood and veins to carry blood away. When either type of vessel is blocked, the nerve cells in the affected area may be starved of oxygen, leading to swelling, bleeding, or permanent cell damage.
These conditions can develop in people with cardiovascular disease, high blood pressure, or diabetes, and they often appear suddenly with little or no warning. A prompt evaluation by a retina specialist is essential when symptoms arise.
Retinal vein occlusion (RVO) occurs when a vein that carries blood away from the retina becomes blocked, causing blood and fluid to back up into the surrounding retinal tissue. There are two main types based on where the blockage occurs.
Branch retinal vein occlusion (BRVO) affects a smaller branch vein and is the more common form. It most often develops at a crossing point where a retinal artery and vein intersect. At these junctions, a hardened or narrowed artery can compress the adjacent vein, restricting blood flow and promoting clot formation. Central retinal vein occlusion (CRVO) affects the main drainage vein for the entire retina and tends to produce more widespread vision changes.
Retinal artery occlusion (RAO) occurs when the artery delivering oxygen-rich blood to the retina becomes blocked. Central retinal artery occlusion (CRAO) affects the main retinal artery and can cause sudden, severe vision loss. Branch retinal artery occlusion (BRAO) involves a smaller branch vessel and may produce a more limited area of vision loss.
The blockage is often caused by an embolus, a small fragment of material such as a cholesterol deposit that travels through the bloodstream and lodges in the artery. It can also result from a thrombus, a clot that forms directly at the site of the blockage. Because retinal tissue can suffer permanent damage within minutes to hours without blood flow, a retinal artery occlusion is a medical emergency.
In retinal vein occlusions, the blocked vein causes blood and fluid to leak into the surrounding retinal tissue. The body also responds by producing higher levels of vascular endothelial growth factor (VEGF), a protein that triggers the growth of new, abnormal blood vessels. These vessels are fragile and prone to bleeding. If they bleed into the vitreous (the clear gel that fills the eye), the result is a vitreous hemorrhage that can severely cloud vision. Abnormal vessel growth on the iris can also lead to a serious form of glaucoma, which refers to elevated pressure inside the eye.
In retinal artery occlusions, the retina is deprived of oxygen very quickly. Without a rapid restoration of blood flow, the affected nerve cells can die. This is why CRAO is sometimes described as a stroke of the eye. The underlying causes are similar to those of a brain stroke, and both conditions share many of the same cardiovascular risk factors.
Who Is at Risk?
Retinal vascular occlusions are more common than many people realize, and the risk factors overlap significantly with those for heart disease and stroke. Knowing your personal risk can help you take meaningful steps to protect your eyes and your overall cardiovascular health.
Retinal vein occlusion is one of the most common retinal vascular disorders, affecting millions of people worldwide. Branch retinal vein occlusion occurs more frequently than central retinal vein occlusion. Retinal artery occlusions are less common but can be devastating in terms of both vision loss and the associated risk of stroke and other vascular events.
The risk factors for retinal vascular occlusions closely mirror those for heart disease and stroke. High blood pressure (hypertension) is the single strongest risk factor and significantly raises the likelihood of developing both BRVO and CRVO. Keeping blood pressure well managed is one of the most protective steps a person can take for their retinal blood vessels.
Other significant risk factors include:
- Diabetes mellitus, which raises blood sugar and damages vessel walls over time
- High cholesterol and elevated triglycerides (hyperlipidemia), which contribute to arterial plaque buildup
- Atherosclerosis (hardening of the arteries) and other forms of heart disease
- Smoking, which damages blood vessel walls and accelerates clotting
The risk of retinal vascular occlusion increases with age, and most patients with retinal artery occlusions are in their 60s or older. Men are affected by retinal artery occlusions somewhat more often than women. Certain findings visible during a routine eye exam, such as arteriovenous nicking (where a hardened artery compresses a crossing vein) and narrowing of small retinal blood vessels, are associated with an elevated risk of branch vein occlusion.
Some people develop retinal vascular occlusions without traditional cardiovascular risk factors, particularly younger patients. In these cases, additional testing for blood clotting disorders or inflammatory conditions may be appropriate.
Recognizing the Symptoms
Retinal vascular occlusions often come on suddenly and without pain, which can make them both alarming and easy to dismiss. Recognizing the warning signs and acting quickly gives you the best possible chance of preserving your vision.
The most common symptom of both BRVO and CRVO is sudden, painless blurring or distortion of vision. This is often caused by macular edema, which is swelling in the macula (the central part of the retina responsible for sharp, detailed vision). In BRVO, the change may affect only part of the visual field, while in CRVO, it tends to be more widespread.
Some patients with CRVO develop a complication called neovascular glaucoma, in which abnormal blood vessels grow on the iris and raise pressure inside the eye. This can cause pain, redness, and sensitivity to light. In some cases, a sudden increase in floaters caused by vitreous hemorrhage is the first noticeable symptom.
Retinal artery occlusion typically causes sudden, severe vision loss in one eye that develops within seconds to minutes. With BRAO, the loss may be limited to one portion of the visual field. Because the blockage deprives retinal tissue of oxygen almost immediately, the window for any effective intervention is extremely narrow.
A retinal artery occlusion can be an early warning sign of stroke and requires immediate medical attention. If you experience sudden vision loss in one eye, please go to an emergency room or contact a retina specialist right away. This is not a situation to observe and monitor at home.
Not every retinal vascular occlusion announces itself dramatically. Some people notice a gradual decline in vision quality over days or weeks, particularly with milder forms of BRVO. Others discover a past occlusion only when a routine eye exam reveals characteristic changes in the retinal blood vessels. Regular dilated eye exams are especially valuable for people with cardiovascular risk factors because they allow early detection before significant vision loss occurs.
How We Diagnose Retinal Vascular Occlusions
Accurate diagnosis requires a combination of a detailed eye examination and specialized imaging technology. Our retina specialists use advanced diagnostic tools to evaluate the extent of the occlusion, identify any complications, and guide individualized treatment decisions.
A retina specialist will begin with a comprehensive eye examination, including a dilated fundus exam. During this exam, special eye drops widen the pupil so the specialist can view the retina in detail. In retinal vein occlusions, characteristic signs include swollen and twisted veins, areas of retinal bleeding, and cotton-wool spots (small white patches that indicate nerve fiber damage from reduced blood flow). In retinal artery occlusions, the affected area may appear pale or whitened due to swelling of nerve cells deprived of oxygen.
Optical coherence tomography (OCT) is a non-invasive imaging test that creates detailed, cross-sectional pictures of the retina. It is especially useful for measuring macular edema and tracking treatment response from visit to visit. OCT angiography, an advanced extension of this technology, can map blood flow through the retinal vessels without requiring dye injection.
Fluorescein angiography is another important diagnostic tool. A special dye is injected into a vein in the arm, and as it travels through the eye's blood vessels, a series of photographs captures areas of blockage, leakage, and abnormal vessel growth. Wide-field imaging allows us to assess the full extent of retinal ischemia (areas of the retina not receiving adequate blood flow), which is critical for identifying complications and planning targeted treatment.
Because retinal vascular occlusions are so closely linked to cardiovascular disease, our specialists often recommend a thorough systemic evaluation alongside eye care. This may include blood pressure measurement, blood sugar and cholesterol testing, and heart rhythm monitoring. For retinal artery occlusions, imaging of the carotid arteries (the large vessels in the neck) may be recommended to identify plaques that could be sending emboli to the eye or the brain. Coordinating with your primary care provider or cardiologist is an important part of comprehensive care following any retinal vascular event.
Treatment Options for Retinal Vascular Occlusions
Treatment depends on the type of occlusion, the severity of vision loss, and whether complications such as macular edema or abnormal blood vessel growth are present. Our retina specialists tailor each treatment plan to the individual patient based on clinical findings, imaging results, and how the eye responds over time.
Anti-VEGF medications work by blocking vascular endothelial growth factor (VEGF), the protein that drives swelling and abnormal vessel growth in the retina. These medications are delivered directly into the vitreous cavity of the eye through a procedure called an intravitreal injection. By reducing VEGF activity, they decrease swelling, slow abnormal blood vessel development, and help preserve or improve vision.
Several anti-VEGF medications are approved for treating retinal vein occlusions. Ranibizumab (Lucentis) was among the first agents approved for this use. Aflibercept (Eylea) is approved for both BRVO and CRVO. Faricimab (Vabysmo) is a newer bispecific agent that targets both VEGF-A and angiopoietin-2 and may allow longer intervals between injections for some patients. High-dose aflibercept (Eylea HD) is another option that may also support extended dosing schedules. Bevacizumab (Avastin) is widely used off-label for retinal vein occlusion and has a well-established track record in clinical practice.
For patients who do not respond adequately to anti-VEGF therapy, or for those with chronic, persistent macular edema, a steroid implant may be considered. The dexamethasone implant (Ozurdex) is a small, biodegradable device injected into the eye that slowly releases corticosteroid medication over several months to reduce inflammation and swelling.
Steroid treatments carry some risks, including elevated eye pressure and an increased likelihood of cataract development (clouding of the eye's natural lens). When a steroid implant is used, our specialists monitor eye pressure closely and adjust care as needed to protect the eye.
Laser photocoagulation, which uses a focused beam of light energy to treat the retina, was historically the standard approach for BRVO with macular edema. While anti-VEGF injections have largely replaced laser as the first-line treatment, laser still plays a role in certain situations. It can be used to treat areas of the retina not receiving adequate blood flow, which may reduce the stimulus for abnormal blood vessel growth. In some patients, laser is used alongside anti-VEGF therapy for a combined approach.
Treatment options for retinal artery occlusions are more limited, and no single intervention has been proven to reliably restore vision after a central retinal artery occlusion, particularly when significant time has passed since the blockage. Emergency measures that may be considered include lowering eye pressure and other supportive interventions. The most critical step following a retinal artery occlusion is a prompt cardiovascular evaluation to assess and reduce the risk of stroke and other serious vascular events.
Research into new treatments for retinal vascular occlusions continues to advance. Biosimilar medications provide additional anti-VEGF options with comparable clinical profiles to established agents. Early-stage research has also explored whether certain medication classes used for diabetes and weight management may have a protective effect on retinal blood vessels, though these findings are still preliminary and require further study before they influence treatment guidelines. Our practice actively participates in clinical research and keeps patients informed about emerging options that may be relevant to their individual care.
What to Expect During and After Treatment
Starting treatment for a retinal vascular occlusion can feel unfamiliar at first, but most patients find that the process becomes routine quickly. We walk you through every step, from your first injection visit to long-term monitoring.
Intravitreal injections are performed in our office during a brief, structured procedure. The eye is numbed with anesthetic drops, the surface is carefully cleaned, and a very fine needle delivers the medication into the vitreous cavity. The injection itself takes only a few seconds. Most patients feel mild pressure during the procedure rather than sharp pain. Afterward, mild soreness, temporary redness, and small floaters are common and typically resolve within a day or two.
Treatment typically begins with a loading phase of more frequent injections over the first several months. After this initial phase, our specialists evaluate how the eye is responding and adjust the schedule accordingly. Some patients are able to extend the time between injections, while others benefit from continuing on a more regular schedule to maintain stable vision.
The visual outcome after a retinal vascular occlusion depends on several factors, including the type of occlusion, how quickly treatment was started, and the overall health of the retina. Many patients with BRVO experience meaningful vision improvement with prompt anti-VEGF treatment. CRVO outcomes are more variable, particularly in eyes with significant ischemia (reduced blood flow affecting a large area of the retina).
For retinal artery occlusions, the outlook for vision recovery is generally more guarded. Because retinal nerve cells are highly sensitive to oxygen deprivation, permanent damage can occur rapidly. Early intervention offers the best possible chance of preserving some vision, though outcomes vary considerably from person to person.
Even after the initial treatment phase, retinal vascular occlusions require ongoing follow-up. Regular visits that include OCT imaging and dilated eye exams allow us to monitor for recurrent macular edema, new abnormal blood vessel growth, or early signs of complications in either eye. Many patients require treatment over months to years, and some benefit from periodic injections on an ongoing basis to maintain stable vision.
Living With Retinal Vascular Occlusions
Managing a retinal vascular occlusion extends well beyond eye care alone. Lifestyle choices and systemic health play a central role in protecting your vision and reducing the risk of future vascular events.
Because retinal vascular occlusions are closely tied to conditions such as high blood pressure, diabetes, and high cholesterol, keeping these conditions under control is essential. Working with your primary care provider to maintain healthy blood pressure, blood sugar, and cholesterol levels helps protect both your retinal blood vessels and your overall cardiovascular health. If you smoke, quitting is one of the most effective steps you can take to reduce the risk of further vascular damage in the eye and throughout the body.
Some patients experience lasting changes in vision after a retinal vascular occlusion, including reduced sharpness, blind spots, or difficulty with activities such as reading or driving. Low vision rehabilitation services can help patients develop practical strategies and use assistive tools to make the most of their remaining vision. Our team can provide referrals to low vision specialists when this type of support would be helpful.
Sudden vision loss is frightening, and it is entirely normal to feel anxious, frustrated, or sad about changes in your sight. The uncertainty of treatment outcomes can add to that stress. We encourage our patients to lean on family, friends, and patient support communities, and to speak openly with our team about how vision changes are affecting daily life. Your emotional health is an important part of your overall care, and we are here to support you through every stage of treatment.
Frequently Asked Questions
Below are answers to questions we commonly hear from patients with retinal vascular occlusions, including guidance on treatment planning, stroke risk, and what to realistically expect from care.
Most retinal vascular occlusions affect one eye at a time, but having an occlusion in one eye does increase the risk of a future event in either eye. This risk reflects the same underlying cardiovascular factors that led to the first occlusion. Consistent management of blood pressure, cholesterol, and blood sugar, combined with regular retinal monitoring, is the most reliable way to reduce that ongoing risk over time.
There is no single timeline that applies to everyone. Some patients respond well and are able to taper to less frequent injections after several months. Others have recurrent macular edema that requires treatment for a year or longer. Newer agents may allow longer intervals between injections for eligible patients, which can meaningfully reduce the overall number of visits required. Your dosing schedule will be guided by how your eye responds at each appointment, rather than a fixed predetermined plan.
Yes, and this connection is clinically significant. A central retinal artery occlusion shares many of the same underlying causes as a brain stroke, including arterial plaque and blood clot formation. Patients who experience a retinal artery occlusion have a meaningfully elevated risk of stroke in the weeks following the event. A prompt cardiovascular evaluation, including imaging of the carotid arteries and a cardiac assessment, is strongly recommended immediately after diagnosis, even before any vision-related symptoms resolve.
Recovery depends on the type of occlusion, the extent of retinal damage before treatment began, and how the eye responds to therapy. Patients with BRVO and macular edema often experience meaningful visual gains with anti-VEGF treatment. Those with severe CRVO or retinal artery occlusion may have more limited recovery, particularly when there was significant ischemia or a delay in starting care. At each visit, we use imaging and examination findings to give you the clearest picture of your progress and realistic expectations going forward.
While no approach can guarantee prevention, managing cardiovascular risk factors substantially lowers your overall risk. Controlling blood pressure, blood sugar, and cholesterol through a combination of a heart-healthy diet, regular physical activity, and medications prescribed by your doctor is the most evidence-supported strategy. Avoiding tobacco use and maintaining a healthy weight also help preserve the integrity of blood vessels throughout the body, including those in the retina.
Go to an emergency room or contact our office immediately if you experience sudden vision loss in one eye, a dark curtain or shadow moving across your field of vision, a sudden dramatic increase in floaters (particularly when accompanied by flashing lights), or severe blurring that does not clear on its own. These symptoms can indicate a retinal artery occlusion, retinal detachment, or vitreous hemorrhage, all of which require urgent evaluation. Do not wait to see if symptoms improve.
We Are Here to Help
At New England Retina Associates, our fellowship-trained retina specialists bring deep expertise to the diagnosis and treatment of retinal vascular occlusions and the full range of retinal conditions. We combine advanced imaging, individualized treatment planning, and active involvement in clinical research to provide every patient throughout Connecticut with the most effective and compassionate care possible. Whether you have been referred by your eye doctor or are reaching out on your own, we welcome the opportunity to evaluate your eyes and help you protect your vision.
30 Years of Care & Commitment
